4
Changes in Ownership
Twist Bioscience Corp Filed Acc 0001214659-26-002041
President and COO sold 5,250 shares at an average $50.16 ($263,359)
- President and COO acquired 3,712 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Finn Patrick John · President and COO
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-02-12 | Exercise or conversion : show line 1 in the form 10b5-1 | +1,000 | $23.33 | $23,330 | 308,788 | D |
| 2026-02-12 | Exercise or conversion : show line 2 in the form 10b5-1 | +1,500 | $26.66 | $39,990 | 310,288 | D |
| 2026-02-12 | Sale : show line 3 in the form 10b5-1 | −3,500 | $50.23 | $175,788 | 306,788 | D |
| 2026-02-13 | Exercise or conversion : show line 4 in the form 10b5-1 | +500 | $23.33 | $11,665 | 307,288 | D |
| 2026-02-13 | Exercise or conversion : show line 5 in the form 10b5-1 | +712 | $26.66 | $18,982 | 308,000 | D |
| 2026-02-13 | Sale : show line 6 in the form 10b5-1 | −1,750 | $50.04 | $87,572 | 306,250 | D |
| Open-market sales · 5,250 sh · avg $50.16 · $263,359 | ||||||
Table II: Derivative
4 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-02-12 | Exercise or conversion : show line 7 in the form 10b5-1 Stock Option (right to buy) | −1,500 | 33,012 | D |
| 2026-02-12 | Exercise or conversion : show line 8 in the form 10b5-1 Stock Option (right to buy) | −1,000 | 18,705 | D |
| 2026-02-13 | Exercise or conversion : show line 9 in the form 10b5-1 Stock Option (right to buy) | −712 | 32,300 | D |
| 2026-02-13 | Exercise or conversion : show line 10 in the form 10b5-1 Stock Option (right to buy) | −500 | 18,052 | D |
Loading xslF345X05/marketforms-72141.xml…